Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Brain imaging

Applications of tau PET imaging

Nature Reviews Neurology volume 13, pages 197–198 (2017)Cite this article

Subjects

Progress in the development of PET radiotracers has enabled the noninvasive assessment of the pathological hallmarks of Alzheimer disease (AD) and other neurodegenerative disorders. New reports have revealed the potential usefulness of tau PET imaging in AD and non-AD tauopathies.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Tau PET images in patients with Alzheimer disease.

References

  1. Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239–259 (1991).

    Article  CAS  PubMed  Google Scholar 

  2. Crary, J. F. et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 128, 755–766 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Villemagne, V. L. et al. Tau imaging: early progress and future directions. Lancet Neurol. 14, 114–124 (2015).

    Article  PubMed  Google Scholar 

  4. Pontecorvo, M. J. et al. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Brain 140, 748–763 (2017).

    PubMed  PubMed Central  Google Scholar 

  5. Murray, M. E. et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol. 10, 785–796 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ossenkoppele, R. et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain 139, 1551–1567 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lowe, V. J. et al. An autoradiographic evaluation of AV-1451 Tau PET in dementia. Acta Neuropathol. Commun. 4, 58 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Passamonti, L. et al. 18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy. Brain 140, 781–791 (2017).

    PubMed  PubMed Central  Google Scholar 

  9. Kikuchi, A. et al. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology 87, 2309–2316 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Giacobini, E. & Gold, G. Alzheimer disease therapy — moving from amyloid-β to tau. Nat. Rev. Neurol. 9, 677–686 (2013).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank R. Harada for substantial contributions to the discussion of content for this article. This study was supported by Grant-in-Aid for Scientific Research (B) (15H04900) and Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (26117003) from MEXT, Japan.

Author information

Authors and Affiliations

  1. Nobuyuki Okamura is at the Division of Pharmacology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981–8558, Japan.,

    Nobuyuki Okamura

  2. Kazuhijo Yanai is at the Department of Pharmacology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-Ku, Sendai 980–8575, Japan.,

    Kazuhiko Yanai

Authors
  1. Nobuyuki Okamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuhiko Yanai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazuhiko Yanai.

Ethics declarations

Competing interests

N.O. is a consultant for CLINO and has received royalties from GE Healthcare.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okamura, N., Yanai, K. Applications of tau PET imaging. Nat Rev Neurol 13, 197–198 (2017). https://doi.org/10.1038/nrneurol.2017.38

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2017.38

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing